# Treating Parkinson's Disease Through Transplantation of Autologous Stem Cell-Derived Dopaminergic Neurons

> **NCT06687837** · PHASE1 · RECRUITING · sponsor: **Jeffrey S. Schweitzer, MD, PhD** · enrollment: 8 (estimated)

## Conditions studied

- Parkinson Disease

## Interventions

- **BIOLOGICAL:** autologous dopaminergic cell implantation

## Key facts

- **NCT ID:** NCT06687837
- **Lead sponsor:** Jeffrey S. Schweitzer, MD, PhD
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-29
- **Primary completion:** 2027-12
- **Final completion:** 2028-12
- **Target enrollment:** 8 (ESTIMATED)
- **Last updated:** 2026-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06687837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06687837, "Treating Parkinson's Disease Through Transplantation of Autologous Stem Cell-Derived Dopaminergic Neurons". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06687837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*